Core Problem Statement

The distinct lack of cost-effective, easily scalable sugar alternatives limits large-scale commercial adoption of healthier product configurations across global food and beverage supply chains.

Solution Overview

A proprietary precision fermentation platform utilizing novel engineered microbial strains to yield clean-label sugar alternatives including Fructooligosaccharides (FOS), Brazzein, and Allulose. The technique relies on advanced genome editing to optimize enzyme synthesis structures for scalable food reformulation.

Strategic Engagement Opportunities

Revelations Biotech’s enzyme processing layouts are built for strategic pilot programs, industrial integration models, and commercial procurement partnerships with global ingredient distributors and food conglomerates.